Growing evidence suggests that the complement system (CS) activation instigates this dysregulated inflammatory reaction in COVID-19: elevated levels of the anaphylatoxin C5a have been reported to be proportional to disease severity (2); the membrane attack complex concentration has been linked with respiratory failure and systemic inflammation in infected patients (3); and deposits of mannose-binding lectin (MBL) and MBL-associated protease MASP-2 have been found in the microvasculature of critical patients with SARS CoV-2 infection (4). The gene discussed is MBL2; the disease is respiratory failure.